CCK-AR Products

Antibodies
CCK-AR Antibody [Unconjugated ...
CCK-AR Antibody [Unconjugated]
AF2680
Species: Hu, Mu, Rt
Applications: WB, IHC
Host: Rabbit Polyclonal
Formulation Catalog # Availability Price  
CCK-AR Antibody
CCK-AR Antibody
NB100-2805
Species: Hu, Rt
Applications: WB, ICC/IF, IHC, IHC-P, PEP-ELISA
Host: Goat Polyclonal
ELISA Kits
Human CCK-AR ELISA Kit (Color ...
Human CCK-AR ELISA Kit (Colorimetric)
NBP2-75057
Species: Hu
Applications: ELISA
Mouse CCK-AR ELISA Kit (Color ...
Mouse CCK-AR ELISA Kit (Colorimetric)
NBP2-75058
Species: Mu
Applications: ELISA
Rat CCK-AR ELISA Kit (Colorim ...
Rat CCK-AR ELISA Kit (Colorimetric)
NBP2-75059
Species: Rt
Applications: ELISA
Lysates
CCK-AR Overexpression Lysate
CCK-AR Overexpression Lysate
NBL1-08839
Species: Hu
Applications: WB

Description

CCKAR is a receptor for cholecystokinin. Mediates pancreatic growth and enzyme secretion, smooth muscle contraction of the gall bladder and stomach. Has a 1000-fold higher affinity for CCK rather than for gastrin. It modulates feeding and dopamine-induced behavior in the central and peripheral nervous system. This receptor mediates its action by association with G proteins that activate a phosphatidylinositol-calcium second messenger system.

Bioinformatics

Entrez Human
Mouse
Rat
Uniprot Human
Human
Human
Mouse
Product By Gene ID 886
Alternate Names
  • CCKRA
  • cholecystokinin type-A receptor
  • CCK1-R
  • cholecystokinin receptor type A
  • CCK-AR
  • CCK-A
  • Cholecystokinin-1 receptor
  • CCK-A receptor
  • cholecystokinin A receptor

Research Areas for CCK-AR

Find related products by research area and learn more about each of the different research areas below.

Diabetes Research
GPCR
Lipid and Metabolism

PTMs for CCK-AR

Learn more about PTMs related to CCK-AR.

Demethylation
Phosphorylation
Methylation

Bioinformatics Tool for CCK-AR

Discover related pathways, diseases and genes to CCK-AR. Need help? Read the Bioinformatics Tool Guide for instructions on using this tool.
 
Vizit™, under license from BioVista Inc.